Latest filing published 09 Jun 2023 for FIBROGEN INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Gerald Lema: trading record in brief
All filings by Gerald Lema on record concern Kyntra Bio, Inc., in the capacity of board member. Between 4 December 2017 and 7 June 2023, the trades on record add up to 7 filings.
Purchases make up the whole of the open-market record (1 purchase, €138k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants.
The newest entry dates from 9 June 2023: a share grant, in Kyntra Bio, Inc. The last purchase on record was published on 5 December 2017, which is 3,261 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gerald Lema
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,289 shares0Common StockSEC:0001209191-23-036077:0
- 15,777 shares0Common StockSEC:0001209191-22-038599:0
- 4,700 shares0Common StockSEC:0001209191-21-036682:0
3 of 3 declarations
